Etiological Characteristics of Bronchopulmonary Pathology in Children, Taking into Account the Microbiota of the Lungs and Intestines

  • Nodira Mamadjanova Basic doctoral student in the 1st year of the Tashkent Paediatric Medical Institute, Uzbekistan
  • Dilfuza Ashurova Doctor of Medicine, Professor at the Tashkent Paediatric Medical Institute, Uzbekistan
Keywords: Respiratory Syndrome infection, causative agents, synobiotic describes, Bacteriological examination, Bronchopulmonary pathologies

Abstract

The intestinal microbiota is known to influence local immune homeostasis in the intestine and shape the developing immune system towards elimination of pathogens and tolerance to self-antigens. Although the lungs have long been considered sterile, recent evidence using sequencing techniques has confirmed that the lower respiratory tract has its own local microbiota. Since then, there has been increasing evidence that local respiratory and intestinal microbiota play a role in acute and chronic lung disease in children

References

1. Sender, R.; Fuchs, S.; Milo, R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016, 14, e1002533. [CrossRef] [PubMed]
2. Kozakova, H.; Schwarzer, M.; Tuckova, L.; Srutkova, D.; Czarnowska, E.; Rosiak, I.; Hudcovic, T.; Schabussova, I.; Hermanova, P.;
3. Zakostelska, Z.; et al. Colonization of germ-free mice with a mixture of three lactobacillus strains enhances the integrity of gut mucosa and ameliorates allergic sensitization. Cell. Mol. Immunol. 2016, 13, 251–262. [CrossRef]
4. Kennedy, E.A.; King, K.Y.; Baldridge, M.T. Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria. Front. Physiol. 2018, 9, 1534. [CrossRef] [PubMed]
5. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 2012, 486, 207–214. [CrossRef]
6. Food and Agriculture Organization (FAO);World Health Organization (WHO). Food and Agriculture Organization and World
7. Health Organization Expert Consultation. Evaluation of Health and Nutritional Properties of Powder Milk and Live Lactic
8. Acid Bacteria. Córdoba, Argentina: Food and Agriculture Organization of the United Nations andWorld Health Organization.
9. 2001. Available online: https://www.fao.org/publications/card/fr/c/7c102d95-2fd5-5b22-8faf-f0b2e68dfbb6/ (accessed on 13 June 2022).
10. Arrieta, M.-C.; Stiemsma, L.T.; Amenyogbe, N.; Brown, E.M.; Finlay, B. The intestinal microbiome in early life: Health and disease. Front. Immunol. 2014, 5, 427. [CrossRef] [PubMed]
11. Arrieta, M.-C.; Stiemsma, L.T.; Dimitriu, P.A.; Thorson, L.; Russell, S.; Yurist-Doutsch, S.; Kuzeljevic, B.; Gold, M.J.; Britton, H.M.;
12. Lefebvre, D.L.; et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci. Transl. Med. 2015, 307,
13. 281re2. [CrossRef] [PubMed] [81] J. Gray, K. Oehrle, G. Worthen, T. Alenghat, J. Whitsett, and H. Deshmukh, “Intestinal commensal bacteria mediate lung mucosal immunity and promote resistance of newborn mice to infection,” Science Translational Medicine, vol. 9, no. 376, article eaaf9412, 2017.
14. T. J. Schuijt, J. M. Lankelma, B. P. Scicluna et al., “The gut microbiota plays a protective role in the host defence againstpneumococcal pneumonia,” Gut, vol. 65, no. 4, pp. 575–583, 2016.
15. X. Ren, Y. Gamallat, D. Liu et al., “The distribution characteristics of intestinal microbiota in children with communityacquired pneumonia under five years of age,” Microbial Pathogenesis, vol. 142, article 104062, 2020.
16. H. T. Groves, L. Cuthbertson, P. James, M. F. Moffatt, M. J. Cox, and J. S. Tregoning, “Respiratory disease following viral lung infection alters the murine gut microbiota,” Frontiers in Immunology, vol. 9, p. 182, 2018.
17. A. T. Vieira, V. M. Rocha, L. Tavares et al., “Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 51A,” Microbes and Infection, vol. 18, no. 3, pp. 180–189, 2016.
18. N. Waki, N. Yajima, H. Suganuma et al., “Oral administration of Lactobacillus brevis KB290 to mice alleviates clinical symptoms following influenza virus infection,” Letters in Applied Microbiology, vol. 58, no. 1, pp. 87–93, 2014.
19. T. Kawahara, T. Takahashi, K. Oishi et al., “Consecutive oral administration of Bifidobacterium longum MM-210 Journal of Immunology Research improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model,” Microbiology and Immunology, vol. 59, no. 1, pp. 1– 12, 2015.
Published
2022-10-12
How to Cite
Mamadjanova, N., & Ashurova, D. (2022). Etiological Characteristics of Bronchopulmonary Pathology in Children, Taking into Account the Microbiota of the Lungs and Intestines. Central Asian Journal of Medical and Natural Science, 3(5), 311-316. https://doi.org/10.17605/cajmns.v3i5.1095
Section
Articles